TK
Trindh Kumar Immani
About Trindh Kumar Immani
Data last updated:
Trindh Kumar Immani is a Director at Revolgene Labs Private Limited (since 2020) and Director at Dai Life Sciences (Opc) Private Limited (since 2026). The companies operate in Pharma. The largest current company by reported revenue is Revolgene Labs Private Limited at ₹68.9 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Revolgene Labs Private Limited U73100KA2020PTC142224 | Director | 15 Dec 2020 | 2020 | ₹68.9 Lakh (FY 2025) | Active |
| Dai Life Sciences (Opc) Private Limited U10799KA2026OPC230104 | Director | 22 Oct 2026 | 2026 | Active |
Board colleagues of Trindh Kumar Immani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nukala Pradeep | 08996976 | Revolgene Labs Private Limited | Director |
| Sushma Ganapathineedi | Dai Life Sciences (Opc) Private Limited | Nominee |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Trindh Kumar Immani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Trindh Kumar Immani
Trindh Kumar Immani currently holds 2 directorships: Revolgene Labs Private Limited (Director, since 15 Dec 2020, revenue ₹68.9 Lakh (FY 2025)); Dai Life Sciences (Opc) Private Limited (Director, since 22 Oct 2026).
Trindh Kumar Immani was first appointed on 15 Dec 2020 as Director at Revolgene Labs Private Limited. The most recent appointment on record is 22 Oct 2026 at Dai Life Sciences (Opc) Private Limited.
The current boards of Trindh Kumar Immani's companies include Nukala Pradeep (Revolgene Labs Private Limited), Sushma Ganapathineedi (Dai Life Sciences (Opc) Private Limited).